Results 131 to 140 of about 3,781 (190)

端粒酶和CYFRA 21-1测定对良恶性胸腔积液的诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2006
目的研究胸腔积液端粒酶活性及CYFRA21-1在良、恶性胸腔积液中的诊断价值。方法用聚合酶链反应—酶联免疫吸附分析法(PCR-ELISA)检测胸腔积液端粒酶活性,用免疫放射分析法(IRA)测定胸液CYFRA21-1水平,并与细胞学诊断结果进行比较,根据最终的诊断结果,67例患者分成2组:(1)非恶性胸腔积液35例;(2)恶性胸腔积液32例。结果非恶性胸腔积液中端粒酶阳性2例(5.7%),恶性胸腔积液阳性26例(81.3%),端粒酶活性测定诊断恶性胸腔积液的灵敏度为81.3%,特异度94%,正确率93 ...
魏仲航, 杨杰, 魏延君
doaj  

CEA、CYFRA21-1和TPS联合检测在非小细胞肺癌中的诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2014
目的探讨癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)、组织多肽特异性抗原(TPS)3项标志物联合检测在非小细胞肺癌(NSCLC)中的诊断价值。方法采用电化学发光法测定保定市第一中心医院90例肺癌患者(肺癌组)和86例健康体检者(对照组)的CEA、CYFRA21-1和TPS 3项标志物水平。结果肺癌组CEA、CYFRA21-1和TPS 3项指标均明显高于对照组 ...
常文龙   +5 more
doaj  

Clinical Significance of CYFRA21-1, AFP, CA-153, CEA, and CA-199 in the Diagnosis of Lung Cancer Ocular Metastasis in Hypertension Population. [PDF]

open access: yesFront Cardiovasc Med, 2021
Tang J   +10 more
europepmc   +1 more source

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer.

open access: yesEvid Based Complement Alternat Med, 2021
Shang L, Zhang W, Wu H, Wu R, Chen R.
europepmc   +1 more source

Levels of Squamous Cell Carcinoma Antigen and Interleukin-6 as Biomarkers in NSCLC Patients [PDF]

open access: yes
Background: Squamous Cell Carcinoma Antigen (SCC-Ag) and Interleukin-6 (IL‐6) has been widely used for monitoring Non-Small Cell Lung Cancer (NSCLC). Objective: This concentration also known to be higher in Non Small Cell Lung Cancer.
Arieta, Lydia   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy